ARCHIVES

ODAC Rejects Amsacrine NDA, Renews Idarubicin

This article is from The Cancer Letter archive.

Vol. 16 No. 35 | September 14, 1990

Download PDF Visit The Full Archive

Related Articles

Bush Limits Drug Company Efforts To Block Generics

October 25, 2002

Interview With AACR’s Margaret Foti: “The Meeting Wouldn’t Have Been The Same.”

April 4, 2003

Research Teams Win Honors For Cancer Immunotherapy Work

October 15, 2010

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

November 4, 1988

NCI Cooperative Group, Cancer Center Trials Listed

May 30, 2008

Colorado Researchers Study Massage To Reduce Symptoms

September 26, 2003